Shaili Gour, PhD, is a postdoctoral scholar in the ALBA Language Neurobiology Lab at the UCSF Edward and Pearl Fein Memory and Aging Center, part of the UCSF Weill Institute for Neurosciences. Her research focuses on understanding why some people with neurodegenerative diseases respond better to treatment than others and how brain changes can help predict recovery.
Gour's current work investigates whether the brain's structure and function can predict an individual's capacity to benefit from therapy for neurodegenerative language disorders. By combining multimodal neuroimaging, behavioral testing, and clinical outcomes, she aims to identify biologically grounded markers that can guide more personalized treatment approaches. Her long-term goal is to help move care for neurodegenerative diseases from trial-and-error approaches toward more precise, prediction-based interventions.
Before joining UCSF, Gour developed expertise in translational neuroscience and biotechnology, with research spanning neurodegeneration, chronic pain, multimodal human neuroimaging, psychophysics, biomarker discovery, randomized controlled trials, and noninvasive brain stimulation, including transcranial direct current stimulation (tDCS). She collaborates with investigators in the Aphasia Research and Treatment Laboratory at The University of Texas at Austin.